Table 4 Results of univariate survival analysis
From: The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer
Univariate Cox regression analysis | |||
|---|---|---|---|
Hazard ratio | 95% confidence interval | P -value | |
Progression-free survival | |||
EGFR positive | 0.55 | 0.26–1.17 | 0.12 |
HER-2/neu positive | 0.98 | 0.46–2.10 | 0.96 |
pEGFR positive | 0.62 | 0.35–1.06 | 0.09 |
pAKT positive | 0.88 | 0.46–1.67 | 0.69 |
pERK positive | 1.09 | 0.77–1.54 | 0.64 |
PTEN negative | 0.48 | 0.32–0.72 | <0.001 |
Overall survival | |||
EGFR positive | 0.84 | 0.43–1.65 | 0.43 |
HER-2/neu positive | 1.02 | 0.48–2.20 | 0.94 |
pEGFR positive | 0.64 | 0.36–1.39 | 0.13 |
pAKT positive | 1.05 | 0.58–1.91 | 0.86 |
pERK positive | 1.04 | 0.73–1.48 | 0.84 |
PTEN negative | 0.66 | 0.44–0.097 | 0.037 |
